Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Drug experts have revealed the two telltale signs that a weight loss jab bought online is fake - and could put you at risk of ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...

Weight loss drugs users should be more cautious when taking their item of choice, top medics warn. after 82 deaths link to the substances.

Until recently, semaglutide injection products had been in short supply ... FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.